Axogen (AXGN) is the leading company focused particularly on the science, advancement and commercialization of technologies for peripheral nerve regeneration and repair. Axogen workers are passionate about restoring peripheral nerve function and quality of life to patients with physical injuries or peripheral nerve segments. offering innovative, clinically proven and cost-effective solutions for surgeons and healthcare providers. Peripheral nerves are responsible for passing motor and sensory signals throughout the body. Every day, other people suffer traumatic injuries or undergo surgeries that serve as support for their peripheral nerves. Physical damage to a peripheral nerve, or the inability to properly reconnect peripheral nerves, can lead to the loss of a muscle or organ, loss of sensory sensation, or the development of pain.
Axogen’s platform for peripheral nerve repair comes with a comprehensive portfolio of products used in two main application categories: non-traumatic scheduled procedures and emergent traumatic procedures. Scheduled procedures are usually characterized as those in which a patient seeks relief from situations caused by a nerve. abnormality or surgery. These procedures come with sensation delivery to women seeking breast reconstruction after mastectomy, nerve reconstruction after surgical removal of painful neuromas, oral and maxillofacial procedures, and nerve decompression. Emergency procedures are typically characterized as procedures resulting from injuries that are first and foremost provided in an emergency room. These procedures are regularly referred and performed by a specialist without delay or within a few days of the initial injury.
Axogen’s product portfolio includes Avance® Nerve Graft, a commercially available, biologically active treated human allograft to join severed peripheral nerves without the comorbidities associated with a momentary surgical site; Axoguard Nerve Connector®, a porcine submucosal ECM coaptation aid for tension-free repair of severed peripheral nerves; Axoguard Nerve Protector®, a porcine submucosal ECM product used to wrap and protect ruptured peripheral nerves and nerve reconstruction while preventing soft tissue attachment; Axoguard HA Nerve Protector™, a porcine submucosal ECM base layer coated with a proprietary hyaluronate-alginate gel, a next-generation generation designed to provide short- and long-term protection against peripheral nerve damage; and Axoguard Nerve Cap®, a porcine submucosal ECM product used to protect the end of a peripheral nerve and separate the nerve from the environment to slow the progression of a symptomatic or painful neuroma. The Axogen product line is available in the United States and Canada. , Germany, the United Kingdom, Spain, South Korea, and several other countries.
Cautionary Statements Regarding Forward-Looking Statements
Contact:Axogen, Inc. Harold D. Tamayo, Vice President of Finance & Inversionistasshtamayo@axogeninc. com Relationships